MedPath

The Vanderbilt University

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Phase 2
Recruiting
Conditions
Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Interventions
Biological: Ipilimumab
Biological: Nivolumab
First Posted Date
2022-05-05
Last Posted Date
2024-07-17
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
54
Registration Number
NCT05361720
Locations
🇺🇸

City of Hope National Medical Center, Duarte, California, United States

🇺🇸

Chao Family Comprehensive Cancer Center, Orange, California, United States

🇺🇸

University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States

and more 3 locations

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

Phase 4
Completed
Conditions
Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Interventions
Procedure: Telemedicine Visit
Procedure: Vital sign measurements
Procedure: Out-Patient Clinic Visit
Procedure: Blood pressure and pulse oximeter
First Posted Date
2021-11-05
Last Posted Date
2025-03-27
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
25
Registration Number
NCT05108805
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Completed
Conditions
Renal Cell Carcinoma
Interventions
Other: Blood collection
Other: Urine collection
First Posted Date
2021-05-12
Last Posted Date
2024-10-22
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
180
Registration Number
NCT04883827
Locations
🇺🇸

Tennessee Valley Health Care System, Nashville, Tennessee, United States

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Improving Care After Inherited Cancer Testing

Not Applicable
Recruiting
Conditions
Inherited Cancer Syndrome
Prostate Cancer
Endometrial Cancer
Colorectal Cancer
Breast Cancer
Interventions
Other: Correlative Studies (Survey)
Other: Correlative Studies (Interview)
Other: Access to Education Materials
Behavioral: Standard-of-care & Adaptive Intervention
Behavioral: GeneSHARE
Behavioral: LivingLabReport
First Posted Date
2021-02-21
Last Posted Date
2025-04-01
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
720
Registration Number
NCT04763915
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Metabolism Informed Smoking Treatment: The MIST RCT

Phase 3
Completed
Conditions
Smoking
Interventions
Behavioral: Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.
Other: Metabolism Informed Smoking Treatment (Nicotine metabolite ratio (NMR)-based selection of pharmacotherapy)
First Posted Date
2020-10-19
Last Posted Date
2025-06-24
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
606
Registration Number
NCT04590404
Locations
🇺🇸

Vanderbilt University Medical Center ViTAL, Vanderbilt Center for Tobacco, Addiction, and Lifestyle General Internal Medicine and Public Health 2525 West End Ave, Suite 450, Nashville, Tennessee, United States

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Phase 2
Recruiting
Conditions
Soft Tissue Sarcomas
Interventions
Radiation: Ultra-Hypo-fractionation Radiotherapy
Procedure: Resection
Radiation: Moderately-Hypo-fractionation Radiotherapy
Other: Questionnaire Administration
First Posted Date
2020-08-10
Last Posted Date
2025-03-28
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
40
Registration Number
NCT04506008
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Phase 1
Active, not recruiting
Conditions
Metaplasia
Stage I Gastric Cancer
Initial-onset Gastric Cancer
Gastric Cancer
Interventions
Procedure: Endoscopy
First Posted Date
2020-07-01
Last Posted Date
2024-07-31
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
15
Registration Number
NCT04454476
Locations
🇯🇵

Nagasaki University Hospital, Nagasaki, Japan

🇯🇵

Nihon University School of Medicine, Tokyo, Japan

🇯🇵

University of Tokyo Medical Center, Tokyo, Japan

COVID-19 and Cancer Consortium Registry

Active, not recruiting
Conditions
Invasive Malignancy (Any Type)
COVID-19
First Posted Date
2020-04-21
Last Posted Date
2024-01-09
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
19275
Registration Number
NCT04354701
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Phase 2
Terminated
Conditions
Thyroid Carcinoma
Radioactive Iodine Level
Interventions
Drug: Artificial Tears
First Posted Date
2020-03-31
Last Posted Date
2024-01-18
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
9
Registration Number
NCT04327999
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Not Applicable
Completed
Conditions
Refractory Cancer
Advanced Cancer
Relapsed Cancer
Interventions
Behavioral: Animal-Assisted Interactions
First Posted Date
2020-03-17
Last Posted Date
2024-08-19
Lead Sponsor
Vanderbilt-Ingram Cancer Center
Target Recruit Count
74
Registration Number
NCT04310345
Locations
🇺🇸

Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy